Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Since the glucose-lowering effects of GIP have been shown to be impaired in patients with T2D, interest has focused on developing antidiabetic therapies based upon the actions of GLP-1 and GIP, the response to which remains intact. To continue reading Log in or register to continue reading
68 Ga-NOTA-MAL-Cys 39 -exendin-4, a potential GLP-1R targeted PET tracer for the detection of Insulinoma
Persistent sneezing accompanied by nasal symptoms warrants GP assessment
Rotate sites to prevent irritation
US$ 27.35
US$ 24.56
US$ 23.99
US$ 21.75
US$ 26.58
US$ 23.47
US$ 21.74
US$ 26.05
US$ 21.00
